Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target
Lead Product(s) : Chitosan-PRP
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Undisclosed
Deal Type : Agreement
Details : The Company will provide the PRP system disposable kits for all enrolled patients in the study. Ortho, has in return, provided the Strategic Company with a right of “first offer” to distribute ORTHO-R in combination with their proprietary PRP System.
Product Name : ORTHO-R
Product Type : Large molecule
Upfront Cash : Undisclosed
February 07, 2022
Lead Product(s) : Chitosan-PRP
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : Phase I/ Phase II
Sponsor : Undisclosed
Deal Size : Undisclosed
Deal Type : Agreement
Lead Product(s) : ORTHO-R
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Study Phase : IND Enabling
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Ortho Regenerative Technologies Receives Clinical Hold Letter from The U.S. FDA
Details : FDA has requested additional CMC related information on Ortho Regenerative's Investigational New Drug application to begin a phase I/II clinical trial for ORTHO-R, its drug/biologic combination product candidate used as an adjunct to SOC surgery in rota...
Product Name : ORTHO-R
Product Type : Undisclosed
Upfront Cash : Not Applicable
June 04, 2021
Lead Product(s) : ORTHO-R
Therapeutic Area : Trauma (Emergency, Injury, Surgery)
Highest Development Status : IND Enabling
Sponsor : Not Applicable
Deal Size : Not Applicable
Deal Type : Not Applicable
Reset All
